Background Several new antithrombotic therapies have emerged for the treatment of acute
coronary syndrome (ACS). We sought to assess contemporary patterns of antithrombotic …

Background— In patients with implantable cardioverter-defibrillators (ICDs), antitachycardia
pacing (ATP) is highly effective in terminating fast ventricular tachycardias (FVTs) and …

Background New diagnosis, risk stratification, and treatment strategies became recently
available for patients with acute pulmonary embolism (PE) leading to changes in clinical …

The coronavirus disease 2019 (COVID-19), a deadly pandemic that has affected millions of
people worldwide, is associated with cardiovascular complications, including venous and …

Background and aims The WHO Global Action Plan for the Prevention of non-communicable
diseases (NCDs) recommends a 30% relative reduction in mean population salt/sodium …

Background Patients with acute venous thromboembolism associated with cancer have an
increased risk of recurrences and bleeding in the long term. Research question To describe …

Introduction Availability of new treatment strategies for patients with acute pulmonary
embolism (PE) have changed clinical practice with potential influence in short-term patients' …

Background and aims Hyperuricemia is a metabolic disorder that has been associated with
adverse cardiovascular (CV) events. Using the data from a nationwide, prospective registry …

It is generally accepted that the current guidelines for the primary prevention of sudden
arrhythmic death, which are based on ejection fraction, do not allow the optimal selection of …

Background: There is an incomplete understanding of the prevalence and predictors of
attainment of low-density lipoprotein cholesterol (LDL-C) goal after myocardial infarction (MI). Aim…